Concepedia

Sietske B.M. Gaykema

SB

Statistics

Publications

6

Citations

413

H-Index

6

Active since

2011

Affiliations

University Medical Center Groningen(Current)

University of Groningen

Sietske B.M. Gaykema is an author at University Medical Center Groningen specializing in medicine, oncology, and her2-positive breast cancer.

Publications per year

2011–2014

6

Publications

6

<sup>89</sup>Zr-Bevacizumab PET Imaging in Primary Breast Cancer

Sietske B.M. Gaykema, Adrienne H. Brouwers, Marjolijn N. Lub–de Hooge et al. · Journal of Nuclear Medicine · 2013 · 166 citations · Full text

, , +14

89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients

Sietske B.M. Gaykema, Carolien P. Schröder, Joanna Vitfell-Rasmussen et al. · Clinical Cancer Research · 2014 · 118 citations

, , +16

<sup>111</sup> In-Trastuzumab Scintigraphy in HER2-Positive Metastatic Breast Cancer Patients Remains Feasible during Trastuzumab Treatment

Sietske B.M. Gaykema, Johan R. de Jong, Patrick J. Perik et al. · Molecular Imaging · 2014 · 47 citations · Full text

, , +17

Zirconium-89-Trastuzumab Positron Emission Tomography As a Tool to Solve a Clinical Dilemma in a Patient With Breast Cancer

Sietske B.M. Gaykema, Adrienne H. Brouwers, Sjoerd Hovenga et al. · Journal of Clinical Oncology · 2011 · 38 citations · Full text

, , +17

Use of biomarkers and imaging to evaluate the treatment effect of AUY922, an HSP90 inhibitor, in patients with HER2+ or ER+ metastatic breast cancer.

C.P. Schröder, J. V. Pedersen, Sue Chua et al. · Journal of Clinical Oncology · 2011 · 25 citations

, , +17

1–5 of 6